The North America Left Atrial Appendage (LAA) Closure Device Market would witness market growth of 18.0% CAGR during the forecast period (2022-2028).
The left atrial appendage (LAA) is a tiny sac in the upper left chamber of the heart that resembles the shape of an ear. During atrial fibrillation, the electrical impulses are controlled by this sac. Left atrial appendage closure devices are percutaneous devices designed to prevent atrial fibrillation-related strokes and emboli.
Market expansion is fueled by factors such as a rise in the number of atrial intervention device approvals, an increase in the incidence of atrial fibrillation as well as heart stroke cases, a rapidly aging population, hypertension-related disorders, and lifestyle disruptions such as smoking. Moreover, growing awareness campaigns in untapped areas provide an abundance of potential opportunities for the market throughout the coming years. These factors are anticipated to propel the expansion of the left atrial appendage closure device market.
In atrial fibrillation, the heart beats irregularly, preventing it from efficiently pumping blood out of the heart and throughout the body. This causes blood to pool or accumulate in the heart, where clots may develop. A stroke can develop if a clot reaches the brain. When blood accumulates in the heart, the left atrial appendage is where it tends to pool.
The regional market is estimated to expand at a rapid rate due to a number of factors, including the high adoption of advanced left atrial appendage closure devices, the rise in the incidence of atrial fibrillation, and the country's well-developed healthcare infrastructure. The U.S. Food and Drug Administration (FDA) has authorized left atrial appendage closure (LAAC) as an alternative to anticoagulation for the prevention of stroke in individuals with nonvalvular atrial fibrillation. Due to these factors, the demand for LAAC is increasing, which is directly augmenting the growth of the left atrial appendage closure devices market in the region.
The US market dominated the North America Left Atrial Appendage (LAA) Closure Device Market by Country in 2021; thereby, achieving a market value of $1,098 million by 2028. The Canada market is experiencing a CAGR of 20.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 20% during (2022 - 2028).
Based on Application, the market is segmented into Geospatial Mapping, Disaster Management, Energy & Resource Management, Surveillance & Monitoring, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Left Atrial Appendage (LAA) Closure Device Market is Predict to reach $4 Billion by 2028, at a CAGR of 19.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Johnson & Johnson (Johnson & Johnson Services, Inc.), Occlutech Holding AG, LifeTech Scientific Corporation, Cardia, Inc. and Lepu Medical Technology Co., Ltd
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospital
- Ambulatory Surgery Centers
- Others
By Product
- Endocardial LAA Devices
- Epicardial LAA Devices
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- AtriCure, Inc.
- Abbott Laboratories
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Occlutech Holding AG
- LifeTech Scientific Corporation
- Cardia, Inc.
- Lepu Medical Technology Co., Ltd
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Left Atrial Appendage (LAA) Closure Device Market, by Application
1.4.2 North America Left Atrial Appendage (LAA) Closure Device Market, by End User
1.4.3 North America Left Atrial Appendage (LAA) Closure Device Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Left Atrial Appendage (LAA) Closure Device Market by End-use
3.1 North America Hospital Market by Country
3.2 North America Ambulatory Surgery Centers Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Left Atrial Appendage (LAA) Closure Device Market by Product
4.1 North America Endocardial LAA Devices Market by Country
4.2 North America Epicardial LAA Devices Market by Country
Chapter 5. North America Left Atrial Appendage (LAA) Closure Device Market by Country
5.1 US Left Atrial Appendage (LAA) Closure Device Market
5.1.1 US Left Atrial Appendage (LAA) Closure Device Market by End-use
5.1.2 US Left Atrial Appendage (LAA) Closure Device Market by Product
5.2 Canada Left Atrial Appendage (LAA) Closure Device Market
5.2.1 Canada Left Atrial Appendage (LAA) Closure Device Market by End-use
5.2.2 Canada Left Atrial Appendage (LAA) Closure Device Market by Product
5.3 Mexico Left Atrial Appendage (LAA) Closure Device Market
5.3.1 Mexico Left Atrial Appendage (LAA) Closure Device Market by End-use
5.3.2 Mexico Left Atrial Appendage (LAA) Closure Device Market by Product
5.4 Rest of North America Left Atrial Appendage (LAA) Closure Device Market
5.4.1 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by End-use
5.4.2 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by Product
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.1.5.2 Approvals and Trials:
6.1.6 SWOT Analysis
6.2 AtriCure, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.3.6 SWOT Analysis
6.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 SWOT Analysis
6.5 Occlutech Holding AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.6 LifeTech Scientific Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Cardia, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology Co., Ltd
6.8.1 Company Overview
TABLE 1 North America Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
TABLE 2 North America Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
TABLE 3 North America Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
TABLE 4 North America Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
TABLE 5 North America Hospital Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Hospital Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
TABLE 12 North America Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
TABLE 13 North America Endocardial LAA Devices Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Endocardial LAA Devices Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Epicardial LAA Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Epicardial LAA Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Left Atrial Appendage (LAA) Closure Device Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Left Atrial Appendage (LAA) Closure Device Market by Country, 2022 - 2028, USD Million
TABLE 19 US Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
TABLE 20 US Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
TABLE 21 US Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
TABLE 22 US Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
TABLE 23 US Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
TABLE 24 US Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
TABLE 25 Canada Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
TABLE 26 Canada Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
TABLE 27 Canada Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
TABLE 28 Canada Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
TABLE 29 Canada Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
TABLE 30 Canada Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
TABLE 31 Mexico Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
TABLE 32 Mexico Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
TABLE 33 Mexico Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
TABLE 34 Mexico Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
TABLE 35 Mexico Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
TABLE 36 Mexico Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
TABLE 37 Rest of North America Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
TABLE 38 Rest of North America Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
TABLE 39 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
TABLE 40 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
TABLE 41 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
TABLE 42 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
TABLE 43 Key Information – Boston Scientific Corporation
TABLE 44 Key Information – AtriCure, Inc.
TABLE 45 Key Information – Abbott Laboratories
TABLE 46 Key Information – Johnson & Johnson (Johnson & Johnson Services, Inc.)
TABLE 47 Key Information – Occlutech Holding AG
TABLE 48 Key Information – LifeTech Scientific Corporation
TABLE 49 Key Information – Cardia, Inc
TABLE 50 Key Information – Lepu Medical Technology Co., Ltd
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Boston Scientific Corporation
FIG 3 SWOT Analysis: Boston Scientific Corporation
FIG 4 Swot analysis: Abbott laboratories
FIG 5 SWOT analysis: Johnson & Johnson